Welcome to our dedicated page for Masimo news (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo stock.
Masimo Corporation (MASI) delivers innovative noninvasive monitoring technologies and premium audio solutions across global markets. This news hub provides investors and industry professionals with timely updates directly from corporate communications and verified financial sources.
Access official press releases covering Masimo's healthcare innovations, including sensor technology advancements and hospital automation systems, alongside developments in its consumer audio division. Our repository tracks regulatory filings, partnership announcements, and clinical validation studies while maintaining strict editorial neutrality.
Key updates include quarterly earnings disclosures, product launch details across both business segments, and strategic corporate actions. Bookmark this page for streamlined monitoring of Masimo's operational milestones and market-moving events in the medical technology sector.
Masimo (NASDAQ: MASI) announced it will release its first quarter 2023 financial results after the market closes on May 9, 2023. A conference call to discuss the results will commence at 1:30 p.m. PT (4:30 p.m. ET), led by Joe Kiani, Chairman and CEO, and Micah Young, CFO. Investors can register for the call to obtain the dial-in details. The company specializes in innovative medical technology and monitoring solutions, boasting the industry-leading Masimo SET® pulse oximetry system. With over 200 million patients monitored globally, it is highly regarded in health care. However, certain products, including ORi and RPVi, have not received FDA clearance in the U.S. More about Masimo.
FAQ
What is the current stock price of Masimo (MASI)?
What is the market cap of Masimo (MASI)?
